Table. Comparison of demographic and clinical characteristics between cases with West Nile fever diagnosed in Israel in 2024 (n = 125) and in 2014–2023 (n = 436) .
| Characteristics | Cases diagnosed in 2024 (n = 125) |
Cases diagnosed 2014–23 (n = 436) |
p | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Cases recorded Jan–Jun | 125 | 100.0 | 61 | 13.9 | < 0.001 |
| Male:female ratio | 1.4 | 1.5 | 0.2 | ||
| Median age in years (IQR) | 71 (50–79) | 65 (47–75) | 0.2 | ||
| Fevera | 90 | 87.4 | 383 | 87.8 | 0.9 |
| Rasha | 46 | 44.7 | 94 | 21.6 | < 0.001 |
| Neuroinvasive diseasea | 64 | 62.1 | 292 | 67.0 | 0.1 |
| Hospitalised | 83 | 66.4 | 395 | 90.6 | < 0.001 |
| Case fatality rate | 12 | 9.6 | 32 | 7.3 | 0.4 |
IQR: interquartile range.
a Clinical data were available for 103 of 125 confirmed cases.
Chi-square tests were used to compare categorical variables and the Student's t-test was used to compare continuous variables. P values greater than 5% were considered statistically significant.
Data for 2024 include all cases reported up to 30 June 2024.